 | Up a level |
Jesson, Julie; Crichton, Siobhan; Quartagno, Matteo; Yotebieng, Marcel; Abrams, Elaine J; Chokephaibulkit, Kulkanya; Le Coeur, Sophie; Aké-Assi, Marie-Hélène; Patel, Kunjal; Pinto, Jorge; Paul, Mary; Vreeman, Rachel; Davies, Mary-Ann; Ben-Farhat, Jihane; Van Dyke, Russell; Judd, Ali; Mofenson, Lynne; Vicari, Marissa; Seage, George; Bekker, Linda-Gail; ... (2022). Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. Journal of the International AIDS Society, 25(3), e25871. BioMed Central 10.1002/jia2.25871
Ford, Nathan; Penazzato, Martina; Vitoria, Marco; Doherty, Meg; Davies, Mary-Ann; Zaniewski, Elizabeth; Tymejczyk, Olga; Egger, Matthias; Nash, Denis (2018). The contribution of observational studies in supporting the WHO 'treat all' recommendation for HIV/AIDS. Journal of virus eradication, 4(Suppl 2), pp. 5-8. Mediscript
Schomaker, Michael; Egger, Matthias; Ndirangu, James; Phiri, Sam; Moultrie, Harry; Technau, Karl; Cox, Vivian; Giddy, Janet; Chimbetete, Cleophas; Wood, Robin; Gsponer, Thomas; Bolton Moore, Carolyn; Rabie, Helena; Eley, Brian; Muhe, Lulu; Penazzato, Martina; Essajee, Shaffiq; Keiser, Olivia; Davies, Mary-Ann and IeDEA-SA, Collaboration (2013). When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS medicine, 10(11), e1001555. Public Library of Science 10.1371/journal.pmed.1001555
Siegfried, Nandi; Davies, Mary-Ann; Penazzato, Martina; Muhe, Lulu M; Egger, Matthias (2013). Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old. Cochrane database of systematic reviews, 10(10), CD010309. WileyInterscience 10.1002/14651858.CD010309.pub2
